Clorox (CLX) Director Stephanie Plaines Receives Award: 338.10 DSUs

What Happened

• Stephanie Plaines, a director of Clorox Co. (CLX), was granted a total of 338.099 deferred stock units (DSUs) reported on the Form 4 filed 2026-04-02. The filing shows two awards: 72.732 DSUs on 2026-02-13 and 265.367 DSUs on 2026-03-31. Both grants are recorded at $0.00 (no cash paid) and are derivative awards rather than open-market purchases or sales.

Key Details

• Transaction types: Award/Grant (derivative) — code A on the Form 4.
• Dates and amounts: 2026-02-13 — 72.732 DSUs @ $0.00; 2026-03-31 — 265.367 DSUs @ $0.00. Total = 338.099 DSUs.
• Report filed: 2026-04-02 (Accession 0001225208-26-004192).
• Shares owned after transaction: not specified in the excerpt provided.
• Timeliness: The 2026-02-13 grant was reported on 2026-04-02 (more than two business days later) and thus appears to be reported late; the 2026-03-31 grant was reported within the typical two-business-day window.
• Footnotes of note:
  • F1: 1-for-1 (each DSU converts 1-for-1 to a Clorox share on settlement).
  • F2: DSUs include amounts acquired via dividend reinvestment under the Independent Directors' Deferred Compensation Plan.
  • F3: DSUs will be settled 100% in Clorox stock upon the director’s retirement or other termination of service.
  • F4: Some DSUs were received in lieu of quarterly director fees.

Context

• DSUs are deferred compensation awards that convert into company shares (per F1/F3) when the director leaves board service; they require no immediate cash outlay and are not the same as an open-market purchase or sale. Such awards are routine for non-employee directors and do not alone indicate a bullish or bearish signal by the insider — value realized will depend on Clorox’s future stock price.